Gene: ELAPOR2
Official Full Name: endosome-lysosome associated apoptosis and autophagy regulator family member 2provided by HGNC
Gene Summary: Predicted to enable BMP receptor binding activity. Predicted to be involved in negative regulation of nervous system development; positive regulation of BMP signaling pathway; and positive regulation of epidermis development. Predicted to be located in plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27164 | ELAPOR2 Knockout cell line (HeLa) | Human | ELAPOR2 | 1:3~1:6 | Negative | Online Inquiry |
KO27165 | ELAPOR2 Knockout cell line (HCT 116) | Human | ELAPOR2 | 1:2~1:4 | Negative | Online Inquiry |
KO27166 | ELAPOR2 Knockout cell line (HEK293) | Human | ELAPOR2 | 1:3~1:6 | Negative | Online Inquiry |
ELAPOR2 Gene Knockout Cell Lines are meticulously engineered mammalian cell lines that contain specific deletions in the ELAPOR2 gene, providing a powerful tool for researchers studying gene function, cellular processes, and intricate signaling pathways. These knockout models allow for the elucidation of the biological roles of ELAPOR2, facilitating in-depth investigation of its involvement in various physiological and pathological contexts.
The core function of ELAPOR2 Gene Knockout Cell Lines lies in their ability to mimic conditions in which the ELAPOR2 gene is naturally deactivated, thereby serving as a model to assess the gene’s contribution to cellular responses and phenotypic alterations. The knockout is achieved through CRISPR/Cas9 technology, ensuring that the gene editing is accomplished with precision and minimal off-target effects. By studying these cell lines, scientists can explore altered growth patterns, changes in metabolic profiles, and the modulation of cell signaling cascades that stem from the absence of functional ELAPOR2.
From a scientific standpoint, these cell lines hold substantial significance in both research and clinical settings, particularly in domains such as cancer biology, immunology, and neurobiology. They enable detailed investigations into how ELAPOR2 impacts disease mechanisms, providing insights that could eventually lead to novel therapeutic strategies or biomarkers.
What sets ELAPOR2 Gene Knockout Cell Lines apart from other genetic models is their specificity and reliability. Unlike conventional knockout models, these cell lines come with extensive validation of gene disruption, providing researchers with confidence in their findings. Additionally, they are compatible with various assays, including drug testing and molecular pathway analysis, making them a versatile asset in any laboratory.
For researchers and clinicians focusing on understanding the genetic underpinnings of diseases and developing targeted interventions, ELAPOR2 Gene Knockout Cell Lines provide an invaluable resource. By utilizing these products, users can significantly enhance the depth and breadth of their research outcomes, driving forward the quest for innovative solutions. Our company is dedicated to advancing scientific knowledge through high-quality biological products, and the ELAPOR2 Gene Knockout Cell Lines exemplify our commitment to excellence in research tools.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.